These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 35328217)

  • 1. Dynamic Change of Albumin-Bilirubin Score Is Good Predictive Parameter for Prognosis in Chronic Hepatitis C-hepatocellular Carcinoma Patients Receiving Transarterial Chemoembolization.
    Lin PT; Teng W; Jeng WJ; Chen WT; Hsieh YC; Huang CH; Lui KW; Hung CF; Wang CT; Chai PM; Lin CC; Lin CY; Lin SM; Sheen IS
    Diagnostics (Basel); 2022 Mar; 12(3):. PubMed ID: 35328217
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Validation and prognostic value of EZ-ALBI score in patients with intermediate-stage hepatocellular carcinoma treated with trans-arterial chemoembolization.
    Ananchuensook P; Sriphoosanaphan S; Suksawatamnauy S; Siripon N; Pinjaroen N; Geratikornsupuk N; Kerr SJ; Thanapirom K; Komolmit P
    BMC Gastroenterol; 2022 Jun; 22(1):295. PubMed ID: 35701739
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hepatic Function during Repeated TACE Procedures and Prognosis after Introducing Sorafenib in Patients with Unresectable Hepatocellular Carcinoma: Multicenter Analysis.
    Hiraoka A; Kumada T; Kudo M; Hirooka M; Koizumi Y; Hiasa Y; Tajiri K; Toyoda H; Tada T; Ochi H; Joko K; Shimada N; Deguchi A; Ishikawa T; Imai M; Tsuji K; Michitaka K;
    Dig Dis; 2017; 35(6):602-610. PubMed ID: 29040999
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Albumin-bilirubin index and platelet-albumin-bilirubin index contribute to identifying survival benefit candidates in patients with hepatocellular carcinoma and Child-Pugh grade A undergoing transcatheter arterial chemoembolization with sorafenib treatment.
    Hu K; Yuan J; Tang B; Zhang F; Lu S; Chen R; Zhang L; Ren Z; Yin X
    Ann Transl Med; 2021 Feb; 9(3):237. PubMed ID: 33708864
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A new ALBI-based model to predict survival after transarterial chemoembolization for BCLC stage B hepatocellular carcinoma.
    Lee IC; Hung YW; Liu CA; Lee RC; Su CW; Huo TI; Li CP; Chao Y; Lin HC; Hou MC; Huang YH
    Liver Int; 2019 Sep; 39(9):1704-1712. PubMed ID: 31319016
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of albumin-bilirubin grade versus Child-Pugh score in predicting the outcome of transarterial chemoembolization for hepatocellular carcinoma using time-dependent ROC.
    Zhao S; Zhang T; Li H; Wang M; Xu K; Zheng D; Du X; Liu L
    Ann Transl Med; 2020 Apr; 8(8):538. PubMed ID: 32411761
    [TBL] [Abstract][Full Text] [Related]  

  • 7. To determine the prognostic value of the albumin-bilirubin grade (ALBI) in patients underwent transarterial chemoembolization for unresectable hepatocellular carcinoma.
    Khalid MA; Achakzai IK; Hanif FM; Ahmed S; Majid Z; Luck NH
    Gastroenterol Hepatol Bed Bench; 2019; 12(2):110-115. PubMed ID: 31191834
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Survival Analysis Using Albumin-Bilirubin (ALBI) Grade for Patients Treated with Drug-Eluting Embolic Transarterial Chemoembolization for Hepatocellular Carcinoma.
    Young LB; Tabrizian P; Sung J; Biederman D; Bishay VL; Ranade M; Patel RS; Nowakowski FS; Fischman AM; Lookstein RA; Kim E
    J Vasc Interv Radiol; 2022 May; 33(5):510-517.e1. PubMed ID: 35150838
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of albumin-bilirubin grade, platelet-albumin-bilirubin grade and Child-Turcotte-Pugh class for prediction of survival in patients with large hepatocellular carcinoma after transarterial chemoembolization combined with microwave ablation.
    Ni JY; Fang ZT; An C; Sun HL; Huang ZM; Zhang TQ; Jiang XY; Chen YT; Xu LF; Huang JH
    Int J Hyperthermia; 2019; 36(1):841-853. PubMed ID: 31452408
    [No Abstract]   [Full Text] [Related]  

  • 10. Clinical Utility of Albumin Bilirubin Grade as a Prognostic Marker in Patients with Hepatocellular Carcinoma Undergoing Transarterial Chemoembolization: a Systematic Review and Meta-analysis.
    Mishra G; Majeed A; Dev A; Eslick GD; Pinato DJ; Izumoto H; Hiraoka A; Huo TI; Liu PH; Johnson PJ; Roberts SK
    J Gastrointest Cancer; 2023 Jun; 54(2):420-432. PubMed ID: 35635637
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Albumin-Bilirubin (ALBI) Grade-Based Nomogram for Patients with Hepatocellular Carcinoma Undergoing Transarterial Chemoembolization.
    Ho SY; Hsu CY; Liu PH; Lee RC; Ko CC; Huang YH; Su CW; Hou MC; Huo TI
    Dig Dis Sci; 2021 May; 66(5):1730-1738. PubMed ID: 32548811
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modified CLIP score with the albumin-bilirubin grade retains prognostic value in HBV-related hepatocellular carcinoma patients treated with trans-catheter arterial chemoembolization therapy.
    Cai XR; Chen ZH; Liu MM; Lin JX; Zhang XP; Chen J; Lin Q; Ma XK; Wen JY; Xie SD; Wu XY; Dong M
    J Cancer; 2018; 9(13):2380-2388. PubMed ID: 30026834
    [No Abstract]   [Full Text] [Related]  

  • 13. Assessment in the Survival Outcome After Transarterial Chemoembolization Combined with Cryoablation for Hepatocellular Carcinoma (Diameter > 4cm) Based on the Albumin-Bilirubin Grade and Platelet-Albumin-Bilirubin ‎grade: ‎ A Preliminary Study.
    Huang Z; Zuo M; Ni J; Gu Y; Zhang T; Jiang Y; Zhuo S; An C; Huang J
    Cancer Manag Res; 2020; 12():1373-1385. PubMed ID: 32158269
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The incidence and predictors of post transarterial chemoembolization variceal bleeding in hepatocellular carcinoma patients.
    Lin PT; Teng W; Jeng WJ; Hsieh YC; Hung CF; Huang CH; Lui KW; Chen YC; Lin CC; Lin SM; Sheen IS; Lin CY
    J Formos Med Assoc; 2020 Feb; 119(2):635-643. PubMed ID: 31495543
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of Pretreatment Albumin-Bilirubin Grade as a Better Prognostic Factor Compared to Child-Pugh Classification in Patients with Hepatocellular Carcinoma Receiving Transarterial Chemoembolization Combined with Radiotherapy.
    Lee JJB; Park JS; Hong HP; Kim MS; Koo DH; Lee H; Nam H
    J Pers Med; 2023 Feb; 13(2):. PubMed ID: 36836588
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cryptogenic hepatocellular carcinoma: characteristics, outcome, and prognostic role of albumin-bilirubin (ALBI) grade vs easy ALBI grade.
    Ho SY; Yuan MH; Liu PH; Hsu CY; Huang YH; Liao JI; Su CW; Wang CL; Hou MC; Huo TI
    Scand J Gastroenterol; 2023 Jan; 58(1):61-69. PubMed ID: 35830511
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Refining Prognosis in Chemoembolization for Hepatocellular Carcinoma: Immunonutrition and Liver Function.
    Müller L; Hahn F; Mähringer-Kunz A; Stoehr F; Gairing SJ; Foerster F; Weinmann A; Galle PR; Mittler J; Pinto Dos Santos D; Pitton MB; Düber C; Kloeckner R
    Cancers (Basel); 2021 Aug; 13(16):. PubMed ID: 34439116
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Eradication of hepatitis C virus profoundly prolongs survival in hepatocellular carcinoma patients receiving transarterial chemoembolization.
    Teng W; Hsieh YC; Lui KW; Chen WT; Hung CF; Huang CH; Chen YC; Jeng WJ; Lin CC; Lin CY; Lin SM; Sheen IS
    J Viral Hepat; 2017 Dec; 24(12):1160-1167. PubMed ID: 28643457
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ALBI and P-ALBI grade in Child-Pugh A patients treated with drug eluting embolic chemoembolization for hepatocellular carcinoma.
    Carling U; Røsok B; Line PD; Dorenberg EJ
    Acta Radiol; 2019 Jun; 60(6):702-709. PubMed ID: 30205701
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison between Child-Pugh Score and albumin-bilirubin grade in patients treated with the combination therapy of transarterial chemoembolization and sorafenib for hepatocellular carcinoma.
    Wang Z; Fan Q; Wang M; Wang E; Li H; Liu L
    Ann Transl Med; 2020 Apr; 8(8):537. PubMed ID: 32411760
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.